In-vitro evaluation of the antimicrobial activity of extracts of bridelia micrantha on selected bacterial pathogens

Journal of Medicinal Plant Research

Volumn 5, Issue 20, 2011, Pages 5116-5122

  Adefuye, A O ^a   Samie, A ^b   Ndip, R N ^a,c  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b UNIVERSITY OF VENDA   (South Africa)

^c UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Bacteria; Bridelia micrantha; Medicinal plant; MIC 50; Solvent extract

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; ANTIINFECTIVE AGENT; BRIDELIA MICRANTHA EXTRACT; CIPROFLOXACIN; DICHLOROMETHANE; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BARK; BIOASSAY; BRIDELIA MICRANTHA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; EUPHORBIA; HELICOBACTER PYLORI; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANT STEM; SALMONELLA TYPHIMURIUM; SHIGELLA SONNEI; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); BRIDELIA MICRANTHA; HELICOBACTER PYLORI; NEGIBACTERIA; POSIBACTERIA; SALMONELLA TYPHIMURIUM; SHIGELLA SONNEI; STAPHYLOCOCCUS AUREUS;

EID: 80054718922     PISSN: None     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Adeleye A, Omonigbehin AE, Stella S, Oluwatosin O, Jumoke S (2008). Antibacterial activity of extracts of Alchornea cordifolia (Schum and Thonn) Mull.Arg, Boerhavia diffusa (L) and Bridelia micrantha (Hoscht) Baill. used in traditional medicine in Nigeria on Helicobacter pylori and four diarrhoeagenic bacterial pathogens. Afr. J. Biotechnol., 7(20): 3761-3764.
2. Ahmed KS, Khan AA, Ahmed I, Tiwari SK, Habeeb A, Ahi JD, Abid Z, Ahmed N, Hahibullah CM (2007). Impact of household hygiene and water sources on the prevalence and transmission of Helicobacter pylori: a South Indian perspective. Singapore Med. J., 48(6): 543-549.
3. Akoachere JF, Tanih NF, Ndip LM, Ndip RN (2009). Phenotypic characterization of Salmonella Typhimurium isolates from food animals and abattoir drains in Buea, Cameroon. J. Health Popul. Nutr., 27(5): 612-618.
4. Banfi E, Scialino G, Monti-Bragadin C (2003). Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility. J. Antimicrob. Chemother., 52: 796-800.
5. Bessong PO, Rojas LB, Obi LC, Tshisikawe PM, Igunbor EO (2006). Further screening of Venda medicinal plants for activity against HIV type 1 reverse transcriptase and integrase. Afr. J. Biotechnol., 5: 526-528.
6. Bizimenyera ES, Swan GE, Samdumu FB, Mc Gaw LJ, Eloff JN (2007). Safety profiles of Peltophorum africanum Sond (Fabaceae) extracts. South Afr. J. Sci., 7: 66-78.
7. Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, Mitov I, Krastev Z (2005). Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J. Med. Microbiol., 54: 481-483.
8. Chiu CH, Chuang CH, Chiu S, Su LH, Lin TY (2006). Salmonella enterica serotype Cholerasius infection in pediatric patients. Pediatrics, 117(6): 1193-1196.
9. Clinical Laboratory Standards Institute (2008). Performance standards for antimicrobial sensitivity testing; disc diffusion supplemental tables. M100-S18, Vol. 28. CLSI, Wayne, PA.
10. Cowan MM (1999). Plant products as antimicrobial agents. Clin. Microbiol. Rev., 12(4): 564-82.
11. Gangoue-pieboji J, Eze N, Djintchui AN, Ngameni B, Tsabang N, Pegnyemb DE, Biyti L, Ngassam P, Koulla-shiro S, Galleni M (2009). The in-vitro antimicrobial activity of some traditionally used plants against beta-lactam-resistance bacteria. J. Infect. Dev. Ctries, 3(9): 671-680.
12. Hakanen AJ, Kotilanen P, Pitkanen S, Hukko S, Siitonen A, Huovinen P (2006). Reduction in fluoroquinolone susceptibility among non typhoidal strains of Salmonella enterica isolated from Finish patients. J. Antimicrob. Chemother., 57: 569-572.
13. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999). Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ, 77: 651-666.
14. Lin J, Puckree T, Mvelase TP (2002). Anti-diarrhoeal evaluation of some medicinal plants used by Zulu traditional healers. J. Ethnopharmacol., 79(1): 123-128.
15. Lemunier M, Francou C, Rousseaux S, Houot S, Dantigny P, Piveteau P, Guzzo J (2005). Long-term survival of pathogenic and sanitation indicator bacteria in experimental bio waste composts. Appl. Environ Microbiol., 71: 5779-5786.
16. Lowy FD (1998). Staphylococcus aureus infections. N. Engl. J. Med., 339: 520-532.
17. Madigan MT, Martinko JM, Parker J (2000). Brock's Biology of Microorganisms, (9th edition). e-Book, p. 120.
18. Masoko P, Mmushi TJ, Mogashoa MM, Mokgotho MP, Mampuru LJ, Howard RL (2008). In vitro evaluation of the antifungal activity of Sclerocarya birrea extracts against pathogenic yeasts. Afr. J. Biotechnol., 7(20): 3521-3526.
19. Mbulaiteye SM, Hisada M, El-Omar EM (2009). Helicobacter pylori associated global gastric cancer burden. Front Biosci., 14: 1490-504.
20. National Nosocomial Infections Surveillance (NNIS) (2001). System report, data summary from January 1992-June 2001. Am. J. Infect. Control, 29: 404-421.
21. Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM, Wirmum C, Efange SMN (2007). In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J. Ethnopharmacol. 114(3): 452-457.
22. Ndip RN, Alertia EMT, Ojongokpoko JEA, Luma HN, Malongue A, Akoachere JFTK, Ndip LM, MacMillan M, Weaver LT (2008). Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop. Med Int. Health, 13 (6): 1-7.
23. Njume C, Afolayan AJ, Ndip RN (2009). An overview of antimicrobial resistance and future of medicinal plants in the treatment of Helicobacter pylori infections. Afr. J. Pharm. Pharmacol., 3(13): 685-699.
24. Nkwelang G, Jane-Francis T, Akoachere K, Kamga LH, Nfoncham ED, Ndip RN (2009). Staphylococcus aureus isolates from clinical and environmental samples in a semi-rural area of Cameroon. Phenotypic characterization of isolates. Afr. J. Microbiol. Res., 3(11): 731-736.
25. Oboh PA, Abulu EO (1997). The antimicrobial activities of extracts of Psidium guajava and Citrus auratifolia. Nig. J. Biotechnol., 8: 25-27.
26. Orwa C, Mutua A, Kindt R, Jamnadass R, Anthony S (2009). Agroforestree Database: a tree reference and selection guide version 4.0 http://www.worldagroforestry.org.
27. Samie A, Obi CL, Bessong PO, Namrita L (2005). Activity profiles of fourteen selected medicinal plants from rural Venda communities in South Africa against fifteen clinical bacterial species. Afr. J. Biotechnol., 4 (12): 1443-1451.
28. Steenkamp V (2003). Traditional herbal remedies used by South African women for gynaecological complaints. J. Ethnopharmacol., 86: 97-108.
29. Steenkamp V, Mokoele TL, Van Rensburg CEJ (2009). Toxicity testing of two medicinal plants, B. micrantha and A. Venosum. Open Toxicol. J., 3: 35-38.
30. Tanih NF, Okeleye BI, Clarke AM, Naidoo N, Mkwetshana N, Green E, Ndip LM, Ndip RN (2010). Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications. South Afr. Med. J., 100: 49-52.